|
MechanismComplement system proteins inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with ET Transplant, Inc.
0 Patents (Medical) associated with ET Transplant, Inc.
100 Deals associated with ET Transplant, Inc.
100 Translational Medicine associated with ET Transplant, Inc.